My second post on this subject, but in case you mi
Post# of 148168
(Total Views: 983)
Posted On: 07/30/2020 11:16:02 PM
My second post on this subject, but in case you missed it or thought I was simply making a conclusion, listen to NP starting at the 6:56 mark.
https://78449.themediaframe.com/dataconf/prod...ndexl.html
NP clearly states that we have efficacy and his statement is not couched by words like "if...", "when...", or "as soon as...", etc.
" As of today, we do have positive efficacy results in our CD10 and the data is still being evaluated to find more positive aspects. In regards to our primary endpoint, clinical improvement was scored in four categories: fever, body ache, difficulty to breathe, and cough. We have seen improvement in day 3 vs. day 0 in leronlimab arm as compared to placebo arm. "
https://78449.themediaframe.com/dataconf/prod...ndexl.html
NP clearly states that we have efficacy and his statement is not couched by words like "if...", "when...", or "as soon as...", etc.
" As of today, we do have positive efficacy results in our CD10 and the data is still being evaluated to find more positive aspects. In regards to our primary endpoint, clinical improvement was scored in four categories: fever, body ache, difficulty to breathe, and cough. We have seen improvement in day 3 vs. day 0 in leronlimab arm as compared to placebo arm. "
(9)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼